COMPANY
Clinical Phase 2
Clarametyx Biosciences is a clinical stage biopharmaceutical company. From company website Source · Oct 12, 2026
Keywords: clinical stage biopharmaceutical Persistent Infection Cystic Fibrosis Community-acquired Pneumonia Bacterial Pneumonia CMTX-101
Location: Columbus, OH · source · Oct 15, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 1/Phase 2: A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis source ↗
- Trial start Phase 1: A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT06159725 | A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis | Phase 1/Phase 2 | Completed | Jun 24, 2024 | Nov 14, 2025 (actual) |
| NCT05629741 | A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 | Phase 1 | Terminated | Nov 14, 2022 | Aug 2, 2024 (actual) |